Skip to main content

Core Scientific Inctx

For the period ended Jun 30, 2024. Filed Aug 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 7, 2024

CORZ$13.13+3.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows (Unaudited)

Condensed Consolidated Statements of Cash Flows

Six Months Ended June 30,
20242023
Cash flows from Operating Activities:
Net loss$(594,205)$(9,648)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization58,47340,567
Amortization of operating lease right-of-use assets2,752469
Stock-based compensation7,43426,553
Digital asset self-mining revenue(260,701)(195,108)
Loss (gain) on debt extinguishment170(20,761)
Change in fair value of energy derivatives(2,262)—
Change in fair value of warrant liabilities809,320—
Change in fair value of contingent value rights(73,379)—
Change in fair value of digital assets41—
Amortization of debt discount1,125—
Losses on disposal of property, plant and equipment3,552174
Impairment of digital assets—2,183
Gain on sale of digital assets—(1,995)
Non-cash reorganization items(143,791)—
Non-cash PIK interest expense2,339—
Changes in operating assets and liabilities:
Accounts receivable, net(3,675)(1,025)
Accounts receivable from related parties—23
Digital assets262,968195,322
Prepaid expenses and other current assets5,654(976)
Accounts payable(11,480)23,282
Accrued expenses and other(46,257)(6,499)
Deferred revenue(1,917)(14,175)
Other noncurrent assets and liabilities, net7,217(409)
Net cash provided by operating activities23,37837,977
Cash flows from Investing Activities:
Purchases of property, plant and equipment(35,029)(1,774)
Investments in internally developed software—(714)
Other(125)—
Net cash used in investing activities(35,154)(2,488)
Cash flows from Financing Activities:
Proceeds from issuance of new common stock55,000—
Proceeds from draw from exit facility20,000—
Principal repayments of finance leases(4,466)(2,260)
Principal payments on debt(28,348)(8,709)
Restricted stock tax holding obligations(3,390)—
Proceeds from exercise of stock options9—
Proceeds from exercise of warrants367—
Net cash provided by provided by (used in) financing activities39,172(10,969)
Net increase in cash, cash equivalents and restricted cash27,39624,520
Cash, cash equivalents and restricted cash—beginning of period69,70952,240
Cash, cash equivalents and restricted cash—end of period$97,105$76,760
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents$96,122$57,593
Restricted cash$983$19,167
Total cash, cash equivalents and restricted cash$97,105$76,760
Supplemental disclosure of other cash flow information:
Cash paid for interest$18,074$742
Income tax refunds$(1,288)$(336)
Cash paid for reorganization items$53,835$—
Supplemental disclosure of noncash investing and financing activities:
Change in accrued capital expenditures$(10,997)$(26,330)
Decrease in equipment related to debt extinguishment—17,849
Decrease in notes payable in exchange for equipment—(38,610)
Reduction in plant, property, and equipment basis related to Bitmain purchase(26,101)—
Reclass of other current and non-current assets to plant, property, and equipment8,187—
Decrease in right-of-use assets due to lease termination(6,560)—
Increase in right-of-use assets due to lease commencement70,690—
Increase in lease liability due to lease commencement69,577—
Extinguishment of convertible notes upon emergence(559,902)—
Extinguishment of accounts payable, accrued expenses, finance lease liability, and notes payable upon emergence(321,773)—
Cancellation of common stock in connection with emergence(37)—
Issuance of new common stock in connection with emergence296,891—
Issuance of new common stock for Bitmain obligation27,839—
Issuance of new common stock for the Equity Rights Offering backstop commitment5,475—
Issuance of contingent value rights86,325—
Issuance of warrants345,856—
Issuance of New Secured Convertible Notes260,000—
Issuance of Secured Notes, net of discount149,520—
Issuance of Exit Credit Agreement including $1.2 million paid in kind upfront fee41,200—
Issuance of miner equipment lender facility loans52,947—
Issuance of notes related to settlement9,092—
Cumulative effect of adoption of ASU 2023-08, Accounting for and Disclosure of Crypto Assets24—
Issuance of new common stock for convertible notes conversion26,390—
Issuance of new common stock for PIK interest3,676—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.